Skip to main content
DNA Labs India

APP Gene Cerebral Amyloid Angiopathy, APP Related NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

APP Gene Cerebral Amyloid Angiopathy, APP Related NGS Genetic Test

Short Name: APP Gene CAA NGS Test

Also known as: APP Gene Mutation Test, CAA Genetic Test, APP Gene NGS Panel

APP Gene Cerebral Amyloid Angiopathy, APP Related NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses NGS Technology on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 weeks from sample receipt. Free home collection in 300+ cities across India.

NGS Genetic TestAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to identify mutations in the APP gene that are associated with cerebral amyloid angiopathy. It aids in confirming a clinical diagnosis, evaluating genetic predisposition, and enabling informed decision making for patients and families.

Test Code
3947
ICD Code
I68.0
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 weeks from sample receipt
Fasting Required
No
Method
NGS Technology
Step 1

Sample Collection

No fasting required. A genetic counselling session is recommended to draw a pedigree chart of family members affected with CAA or other neurological disorders.

Method: Venipuncture or Dried Blood Spot

Step 2

Laboratory Analysis

A small amount of blood will be drawn from a vein in your arm, or a few drops of blood will be placed on an FTA card for dried blood spot analysis.

Step 3

Report Delivery

You can resume normal activities. There are no restrictions after the sample collection.

Timeline: 3 to 4 weeks from sample receipt

Patient Instructions

1
Before the Test:No special preparation is required. However, a genetic counselling session is advised to draw a pedigree chart of family members affected with APP gene-related disease.
2
During the Test:Blood sample collection is quick and should take less than 5 minutes.
3
After the Test:You can go home. Results will be sent in 3-4 weeks via email and online portal.

About This Test

Who Should Get This Test

The purpose of this test is to identify mutations in the APP gene that are associated with cerebral amyloid angiopathy. It aids in confirming a clinical diagnosis, evaluating genetic predisposition, and enabling informed decision making for patients and families.

How to Prepare

  • Please carry a government-issued photo ID
  • Provide detailed clinical history and family pedigree
  • Inform the lab if you have received a blood transfusion or bone marrow transplant in the past 3 months

Doctor's Notes

Reviewed by — MBBS, MD (Pathology) · Reg. No. 21521

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume5 ml blood or 1 drop for FTA card
ContainerEDTA tube or FTA card
Collection MethodVenipuncture or Dried Blood Spot

Sample Stability

Ambient temperature
Refrigerated (2-8°C)
Frozen (-20°C)
Sample Rejection Criteria:
  • Sample received in improper container
  • Insufficient sample quantity
  • Sample leaking or unstable

Understanding Your Results

The test report provides an interpretation of the detected variants in the APP gene. The clinical significance of each variant is determined based on established guidelines.
📊

No pathogenic variant detected

Negative for known pathogenic mutations in the APP gene. Risk of APP-related CAA is not elevated based on this gene.

📊

Pathogenic variant detected

Presence of a disease-causing mutation; increased risk for cerebral amyloid angiopathy.

📊

Variant of uncertain significance (VUS)

A genetic change with unclear impact on disease. Further testing of family members may be needed.

⚠️ When to Consult a Doctor:

Consult a neurologist or clinical geneticist if you have symptoms such as recurrent lobar haemorrhage, unexplained headaches, cognitive decline, or a family history of CAA.

Limitations

  • This test is not intended for prenatal screening
  • May not detect large deletions, insertions, or structural rearrangements
  • A negative result does not exclude all forms of CAA, as other genes or factors may be involved
  • Variants of uncertain significance may require additional family studies

Risks & Considerations

  • Minor bruising at the injection site
  • Dizziness or lightheadedness during blood draw
  • Potential psychological distress from test result

Interfering Factors

  • Recent bone marrow transplant or allogeneic stem cell transplant
  • Blood transfusion within the past 3 months may affect DNA analysis
  • Contaminated or hemolyzed blood samples

Frequently Asked Questions

What is the cost of the APP gene CAA NGS genetic test?
The APP Gene Cerebral Amyloid Angiopathy, APP Related NGS Genetic Test at DNA Labs India costs INR 20,000. This includes home sample collection in selected cities.
What is the purpose of this test?
This test detects mutations in the APP gene that are associated with cerebral amyloid angiopathy. It is used for risk assessment, confirmation of diagnosis, and genetic counselling.
Who should consider taking this test?
Individuals with symptoms of CAA, a family history of CAA, or those with unexplained lobar haemorrhage should consider this test. Your neurologist or geneticist may recommend it.
How is the sample collected?
The sample can be collected as a blood sample, extracted DNA, or a single drop of blood placed on an FTA card. Our technician can collect the sample at home.
Do I need to fast before the test?
No, fasting is not required for this genetic test.
What is the turnaround time?
The test results are typically delivered within 3 to 4 weeks from the date the sample is received at the laboratory.
How will I receive my report?
Your report will be sent through email, WhatsApp, and the online portal. You can also download it from your DNA Labs India account.
Can a positive result confirm I have CAA?
A positive result indicates the presence of a pathogenic APP mutation, which confirms a hereditary risk for CAA. Clinical correlation with brain imaging and neurological examination is necessary.
What are the limitations of this test?
The test analyses only the APP gene. It may not detect large gene rearrangements, and a negative result does not completely rule out CAA caused by other genes.
Is the test covered by insurance?
Coverage depends on your insurance provider and policy. You should check with your insurer. The test is not routinely covered under government schemes.
Is home sample collection available?
Yes, free home sample collection is available for online bookings in more than 100 cities across India, including Mumbai, Delhi, Bangalore, Hyderabad, and others.
How do I book the test?
You can book online through the DNA Labs India website or by calling our customer care. A technician will be scheduled at your convenience.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.